These results indicate that the role of MS4A7 in a variety of tumor microenvironments and the impact of its expression on patient prognosis are almost consistent with the results of GBM tumors, and MS4A7 is an important factor associated with the suppression of macrophage inflammatory responses. Here, MS4A7 is linked to glioblastoma.